Crossmark

Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis

Crossref DOI link: https://doi.org/10.1016/j.gastre.2024.04.031

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodríguez-Moranta, Francisco

Argüelles-Arias, Federico

Hinojosa del Val, Joaquín

Iborra Colomino, Marisa

Martín-Arranz, M. Dolores

Menchén Viso, Luis

Muñoz Núñez, Fernando

Ricart Gómez, Elena

Sánchez-Hernández, José Germán

Valdés-Delgado, Teresa

Guardiola Capón, Jordi

Barreiro-de Acosta, Manuel

Mañosa Ciria, Míriam

Zabana Abdo, Yamile

Gutiérrez Casbas, Ana
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-05-17
More Information

This article is maintained by: Elsevier

Article Title: Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2024.04.031

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2024.01.007

Content Type: simple-article

Copyright: © 2024 The Author(s). Published by Elsevier España, S.L.U.